Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

RMJ. 2011; 36(1): 38-40

Role of fluoxetine and nortriptyline in major depressive disorders

Ghulam rasool Bhurgri, Hussain Bux Korejo, Mohammad Ali Qureshi.

To assess the effectiveness and safety of fluoxetine and nortriptyline in major depressive disorders
Patients and Methods
This study was conducted in Sir Cowsee Jee Jehangie Institute of Psychiatry, Hyderabad in collaboration with Department of Pharmacology and Therapeutics Mohammad Medical College Mirpur Khas, from January 2009 to June 2009. Following a 1-week washout period, patients were randomly assigned to 12 weeks of parallel treatment with either fluoxetine (in a flexible daily dose of 20-80 mg) and nortriptyline (in a flexible daily dose of 25–100 mg) provided on a three times per day schedule. Clinical response was seen on weekly follow up basis.
A total of 192 patients were included in this study. In the fluoxetine group, mean age was 38.28.8 years. In the Nortriptyline group, mean age was 39.511.6 years. At week-1, the gain in fluoxetine was - 55.4 15.3 and in nortriptyline group it was - 35.4 10.4 (P < 0.0001). Nausea and headache were common in nortriptyline 14.6% and 12.5% respectively and in Fuoxetine 4.2% and 4.2% respectively.
This study provides evidence in favor of efficacy and advantages of fluoxetine over Nortriptyline. Fluoxetine can be considered as first choice in pharmacological treatment of this disorder. Nausea and headache occurred more in nortriptyline than fluoxetine. (Rawal Med J 2011;36:38-40).

Key words: Depression, fluoxetine, nortriptyline, SSRI.

Full-text options

Full-text Article

Oxidants and Antioxidants in Medical Science


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.